Discovery of A-770041, a Src-Family Selective Orally Active Lck Inhibitor that Prevents Organ Allograft Rejection.
Burchat, A., Borhani, D.W., Calderwood, D.J., Hirst, G.C., Li, B., Stachlewitz, R.F.(2006) Bioorg Med Chem Lett 16: 118
- PubMed: 16216497 
- DOI: https://doi.org/10.1016/j.bmcl.2005.09.039
- Primary Citation of Related Structures:  
2C0I, 2C0O, 2C0T - PubMed Abstract: 
We describe the identification, SAR, and pharmacology of the src-family selective lck inhibitor A-770041 that prolongs the survival of major histocompatibility mismatched allografts in models of solid organ transplant rejection for greater than 65 days.
Organizational Affiliation: 
Abbott Bioresearch Center, 100 Research Drive, Worcester, MA 01605-5314, USA.